Fosun Pharma Announces 2021 Interim Results
Innovative Products Continuously Launched with International Operation Capability Further Improved
Highlights
- Revenue amounted to RMB16,952 million, a year-on-year increase of 20.85%, of which, the income from regions outside Chinese Mainland and overseas…
